ARCHIVES

ACS Funds $54 Million in Grants

This article is from The Cancer Letter archive.

Vol. 28 No. 26 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

Clinical Trials Approved Last Month By NCI’s CTEP

May 31, 2002

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994